Back
Astellas Pharma Vs. Nxera Pharma Industry Stock Comparison
Sell
40
ALPMF
Astellas Pharma
Last Price:
9.56
Seasonality Move:
5.36%
Sell
44
SOLTF
Nxera Pharma
Last Price:
9.72
Seasonality Move:
-0.32%
Sell
40
Astellas Pharma (ALPMF)
is a Sell
Is Astellas Pharma a Buy, Sell or Hold?
- The current Astellas Pharma [ALPMF] share price is $9.56. The Score for ALPMF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ALPMF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $9.72. The Score for SOLTF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALPMF Stock Price Chart
What is Astellas Pharma's stock price today?
-
The Astellas Pharma share price today is $9.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALPMF is experiencing slight buying pressure.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $9.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOLTF is experiencing slight buying pressure.
ALPMF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 42.84 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.42 - 9.86) | Sell |
Bollinger Bands (100): | (10.02 - 11.78) | Sell |
SOLTF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 47.62 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.41 - 9.89) | Buy |
Bollinger Bands (100): | (9.24 - 10.8) | Sell |
ALPMF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.85 | Sell |
20-day SMA: | 9.68 | Sell |
50-day SMA: | 10.27 | Sell |
200-day SMA: | 12.15 | Sell |
8-day EMA: | 9.79 | Sell |
20-day EMA: | 9.81 | Sell |
50-day EMA: | 10.19 | Sell |
200-day EMA: | 11.81 | Sell |
SOLTF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.75 | Sell |
20-day SMA: | 9.6 | Buy |
50-day SMA: | 10.18 | Sell |
200-day SMA: | 10.14 | Sell |
8-day EMA: | 9.72 | Buy |
20-day EMA: | 9.73 | Sell |
50-day EMA: | 9.87 | Sell |
200-day EMA: | 10.76 | Sell |
Astellas Pharma Earnings Growth & ALPMF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Astellas Pharma Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nxera Pharma Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |